Literature DB >> 12452373

Cholecystokinin and secretin and pancreatic secretion of insulin and glucagon.

Fuad Lechin, Bertha van der Dijs, Beatriz Orozco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12452373     DOI： 10.1023/a:1020583203761

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  15 in total

1.  Adrenergic-serotonergic influences on gallbladder motility and irritable bowel syndrome.

Authors:  F Lechin
Journal:  Am J Physiol       Date:  1992-02

2.  Effects of secretin on insulin and glucagon in portal and peripheral blood in man.

Authors:  J Dupré; L Rojas; J J White; R H Unger; J C Beck
Journal:  Lancet       Date:  1966-07-02       Impact factor: 79.321

3.  Mechanism of epinephrine and serotonin inhibition of insulin release in the golden hamster in vitro.

Authors:  J M Feldman; H E Lebovitz
Journal:  Diabetes       Date:  1970-07       Impact factor: 9.461

4.  Beta-adrenergic stimulation and insulin release in dogs following HB 419.

Authors:  O V Sirek; M Vigas; A Niki; H Niki; A Sirek
Journal:  Diabetologia       Date:  1969-08       Impact factor: 10.122

5.  Effects of adrenergic and cholinergic agents upon insulin secretion in vitro.

Authors:  W Malaisse; F Malaisse-Lagae; P H Wright; J Ashmore
Journal:  Endocrinology       Date:  1967-05       Impact factor: 4.736

6.  Effect of exogenous cholecystokinin and secretin on pancreatic secretion of insulin and glucagon in rats: in vivo model without hepatic filter.

Authors:  R L Ferrer; J Medrano; R Calpena; M Diego; M L Graells; M V Molto; M T Pérez; M I Oliver; G M Salido
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

7.  Glucose tolerance, non-nutrient drink, and gastrointestinal hormones.

Authors:  F Lechin; B van der Dijs
Journal:  Gastroenterology       Date:  1981-01       Impact factor: 22.682

8.  Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.

Authors:  R H Unger; A Ohneda; I Valverde; A M Eisentraut; J Exton
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

9.  Inhibition of insulin release by norepinephrine in man.

Authors:  D Porte; R H Williams
Journal:  Science       Date:  1966-05-27       Impact factor: 47.728

10.  The gastrointestinal stimulus to insulin release. I. Secretin.

Authors:  D J Chisholm; J D Young; L Lazarus
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808
View more
  2 in total

Review 1.  Central nervous system plus autonomic nervous system disorders responsible for gastrointestinal and pancreatobiliary diseases.

Authors:  Fuad Lechin; Bertha van der Dijs
Journal:  Dig Dis Sci       Date:  2008-07-16       Impact factor: 3.199

2.  Amantadine reduces glucagon and enhances insulin secretion throughout the oral glucose tolerance test: central plus peripheral nervous system mechanisms.

Authors:  Fuad Lechin; Bertha van der Dijs; Betty Pardey-Maldonado; Jairo E Rivera; Marcel E Lechin; Scarlet Baez
Journal:  Diabetes Metab Syndr Obes       Date:  2009-12-02       Impact factor: 3.168
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.